Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dichloroacetate for plateau-phase multiple myeloma
ACTRN12615000226505Phase 2Recruiting
- Sponsor
- Capital Region Cancer Services
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dichloroacetate in multiple myeloma (MM), sponsored by Capital Region Cancer Services. Primary endpoint: Overall response rate. Started May 2015; status: recruiting.
02
Drugs
dichloroacetate
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ACTRN12615000226505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000226505.